ITCC-091 FaR-RMS
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma
Promotor Name : Eli Lilly
Investigator Name : J. MERIEL
Trial registered on clinicaltrial.gov: NCT04625907
ITCC-091 FaR-RMS
Innovative Therapies
for Children with Cancer in Europe-
Contact us
